A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
PHASE4TerminatedINTERVENTIONAL
Enrollment
262
Participants
Timeline
Start Date
April 30, 2006
Study Completion Date
November 30, 2006
Conditions
Macular Degeneration
Interventions
DRUG
Pegaptanib sodium
Trial Locations (1)
28210
Charlotte Eye, Ear, Nose and Throat Associates, P.A., Charlotte